Publication
Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis
| dc.contributor.author | Oliveira, AT | |
| dc.contributor.author | Lopes, S | |
| dc.contributor.author | Cipriano, MA | |
| dc.contributor.author | Sofia, C | |
| dc.date.accessioned | 2016-12-15T14:48:02Z | |
| dc.date.available | 2016-12-15T14:48:02Z | |
| dc.date.issued | 2015-07-21 | |
| dc.description.abstract | A 33-year-old woman with multiple sclerosis, medicated with high doses of methylprednisolone, cyclophosphamide and glatiramer acetate, was referred to our department due to acute liver injury. The laboratory investigation was normal except for weakly positive antinuclear antibodies. Cyclophosphamide and glatiramer acetate were suspended, and intravenous immunoglobulin with maintenance of high doses of methylprednisolone was initiated. The patient developed another episode of acute hepatitis so the immunoglobulin was stopped. After that, she had three more episodes of elevation of liver enzymes with no hepatic insufficiency while medicated only with high doses of methylprednisolone. At this time, liver biopsy showed focal centrilobubar hepatocyte necrosis with minimal interface hepatitis. After the high doses of methylprednisolone were suspended, the patient remained asymptomatic, with normal hepatic enzymes. This case emphasises that, although rare, induced liver injury after high doses of methylprednisolone can occur. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | BMJ Case Rep. 2015 Jul 21;2015. pii: bcr2015210722. | pt_PT |
| dc.identifier.doi | 10.1136/bcr-2015-210722 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.4/2005 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Lesão hepática Induzida por Químicos e Medicamentos | pt_PT |
| dc.subject | Esclerose Múltipla | pt_PT |
| dc.subject | Biopsia | pt_PT |
| dc.subject | Metilprednisolona | pt_PT |
| dc.title | Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | bcr2015210722 | pt_PT |
| oaire.citation.volume | 2015 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |